| Alternative name 1: |
&, 14kD, 16, 20, Clone: 5C9, Mab anti-Human, WB, ~24, BID |
| Alternative name 2: |
&, 14kD, 16, 20, Clone: 5C9, Mab antibody-Human, WB, ~24, BID |
| Alternative name 3: |
&, 14kD, 16, 20, Clone: 5C9, Mab antibody-Homo sapiens, WB, ~24, BID |
| Alternative name 4: |
14kD Clone: 5C9, anti-BID ~24 20 16 & |
| Alternative name 5: |
14kD Clone: 5C9, BID ~24 20 16 & |
| Clonality: |
Monoclonal Antibody |
| Description: |
Amongst the advantages of the monoclonal antibodies are: the fact that while the hybridoma takes a bit longer to be produced, If used correctly and according the protocol, in comparison to the polyclonal antibodies monoclonal antibodies are highly specific to a given epitope and can be used in applications where specific targeting is required, once the line is ready there is virtually an endless supply of these antibodie throughout time with little to no variations in recognition sites of the antigen in different batches, this antibody will provide excellent and reproducible results with guaranteed success for the tested and confirmed applications, This is a monoclonal antibody which is greatly purified and with high binding affinity for the antigen that it is risen against |
| Storage and handling: |
Antibodies in a liquid form can be shipped and stored for a short period of time at +4 degrees Celsius, antibodies that are lyophilized can be transported at ambient temperature and stored for short terms at +4 degrees Celsius, for long term storage (up to one year) 25-50% glycerol or ethylene glycol should be added and then the container has to be stored at -20°, for longer periods - at -20 , C, Generally |
| Advisory: |
For antibodies in a liquid form or reconstituted lyophilized antibodies small amounts of the soultion could be captured on the cap or the walls of the container, Right before use you could briefly centrifuge the vial to collect all of the solution on the bottom, To keep the quality and the affinity of the antibody cycles of freezing and thawing should be avoided |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| About: |
Each murine monoclonal anibody has his own affinity specific for the clone, Mouse monoclonal antibodies are purified protein A or G and can be conjugated to FITC for flow cytometry or FACS and can be of different isotypes, Monoclonals of this antigen are available in different clones |
| Test: |
A/J, BALB/c, Mouse are mature after 40 days for females and 55 days for males, SCID while the CD-1 is outbred as strain, The female mice are pregnant only 20 days and can give birth to 10 litters of 6-8 mice a year, Transgenic, congenic and inbread strains are known for C57BL/6, knock-out, Mouse , mice from the Mus musculus species are used for production of mouse monoclonal antibodies or mabs and as research model for humans in your lab, or |
| Latin name: |
Mus musculus |
| French translation: |
anticorps |
| Gene target: |
14kD, 16, 20, 5C9, Monoclonal, ~24, BID |
| Short name: |
14kD, 16, 20, Clone: 5C9, Mouse Monoclonal antibody-, ~24, BID |
| Technique: |
Monoclonals or monoclonal antibodies, mouses, Mouse |
| Species: |
Humans, Mouses, Human |
| Alternative name: |
&, 14kD, 16, 20, Mouse monoclonal (Antibody to)-H, Western Blot, clonality: 5C9, sapiens, ~24, BH3 interacting domain death a this GO nist |
| Alternative technique: |
murine |
| Alternative to gene target: |
BID and IDBG-1050 and ENSG00000015475 and 101929618, BID and IDBG-641320 and ENSBTAG00000013988 and 510373, Bid and IDBG-184076 and ENSMUSG00000004446 and 12122, FP497, Plasma membranes, this GO :0001836 and release of cytochrome c from mitochondria and biological process this GO :0005123 and death receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005739 and mitochondrion and cellular component this GO :0005741 and mitochondrial outer membrane and cellular component this GO :0005829 and cytosol and cellular component this GO :0006626 and protein targeting to mitochondrion and biological process this GO :0006915 and apoptotic process and biological process this GO :0006919 and activation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0007420 and brain development and biological process this GO :0008625 and extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :0008637 and apoptotic mitochondrial changes and biological process this GO :0016020 and membrane and cellular component this GO :0031625 and ubiquitin protein ligase binding and molecular function this GO :0032355 and response to estradiol and biological process this GO :0032459 and regulation of protein oli this GO merization and biological process this GO :0032461 and positive regulation of protein oli this GO merization and biological process this GO :0032464 and positive regulation of protein homooli this GO merization and biological process this GO :0032592 and integral component of mitochondrial membrane and cellular component this GO :0034349 and glial cell apoptotic process and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042770 and signal transduction in response to DNA damage and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0045087 and innate immune response and biological process this GO :0051260 and protein homooli this GO merization and biological process this GO :0051402 and neuron apoptotic process and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0090150 and establishment of protein localization to membrane and biological process this GO :0090200 and positive regulation of release of cytochrome c from mitochondria and biological process this GO :0097191 and extrinsic apoptotic signaling pathway and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :1900740 and positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway and biological process this GO :1901030 and positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway and biological process this GO :1902108 and regulation of mitochondrial membrane permeability involved in apoptotic process and biological process this GO :2000045 and regulation of G1/S transition of mitotic cell cycle and biological process this GO :2001238 and positive regulation of extrinsic apoptotic signaling pathway and biological process this GO :2001244 and positive regulation of intrinsic apoptotic signaling pathway and biological process, this GO :0005123 : death receptor binding, this GO :0005123 : death receptor binding and also this GO :0005515 : protein binding and also this GO :0031625 : ubiquitin protein ligase binding, this GO :0005515 : protein binding, this GO :0031625 : ubiquitin protein ligase binding, ubiquitin protein ligase binding, 637, 782484, BH3 interacting domain death a this GO nist |
| Identity: |
1050 |
| Gene: |
BID |
More about : BID |
| Long gene name: |
BH3 interacting domain death agonist |
| Locus: |
22q11, 21 |
| Discovery year: |
1998-04-20 |
| GenBank acession: |
AF042083 |
| Entrez gene record: |
637 |
| Pubmed identfication: |
8918887 9721221 |
| RefSeq identity: |
NM_197966 |
| Classification: |
Endogenous ligands BCL2 homology region 3 (BH3) only |
| Havana BLAST/BLAT: |
OTTHUMG00000150087 |